These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Crystallographic studies on structural features that determine the enzymatic specificity and potency of human angiogenin: Thr44, Thr80, and residues 38-41. Holloway DE, Chavali GB, Hares MC, Baker MD, Subbarao GV, Shapiro R, Acharya KR. Biochemistry; 2004 Feb 10; 43(5):1230-41. PubMed ID: 14756559 [Abstract] [Full Text] [Related]
3. Structural features that determine the enzymatic potency and specificity of human angiogenin: threonine-80 and residues 58-70 and 116-123. Shapiro R. Biochemistry; 1998 May 12; 37(19):6847-56. PubMed ID: 9578571 [Abstract] [Full Text] [Related]
5. Crystallographic studies on the role of the C-terminal segment of human angiogenin in defining enzymatic potency. Leonidas DD, Shapiro R, Subbarao GV, Russo A, Acharya KR. Biochemistry; 2002 Feb 26; 41(8):2552-62. PubMed ID: 11851402 [Abstract] [Full Text] [Related]
6. Crystal structure of human angiogenin reveals the structural basis for its functional divergence from ribonuclease. Acharya KR, Shapiro R, Allen SC, Riordan JF, Vallee BL. Proc Natl Acad Sci U S A; 1994 Apr 12; 91(8):2915-9. PubMed ID: 8159679 [Abstract] [Full Text] [Related]
7. Three-dimensional structure of a human pancreatic ribonuclease variant, a step forward in the design of cytotoxic ribonucleases. Pous J, Canals A, Terzyan SS, Guasch A, Benito A, Ribó M, Vilanova M, Coll M. J Mol Biol; 2000 Oct 13; 303(1):49-60. PubMed ID: 11021969 [Abstract] [Full Text] [Related]
13. Crystal structure of human angiogenin with an engineered loop exhibits conformational flexibility at the functional regions of the molecule. Thiyagarajan N, Acharya KR. FEBS Open Bio; 2013 Sep 01; 3():65-70. PubMed ID: 23772376 [Abstract] [Full Text] [Related]
15. High-resolution crystal structures of ribonuclease A complexed with adenylic and uridylic nucleotide inhibitors. Implications for structure-based design of ribonucleolytic inhibitors. Leonidas DD, Chavali GB, Oikonomakos NG, Chrysina ED, Kosmopoulou MN, Vlassi M, Frankling C, Acharya KR. Protein Sci; 2003 Nov 01; 12(11):2559-74. PubMed ID: 14573867 [Abstract] [Full Text] [Related]
17. Binding of phosphate and pyrophosphate ions at the active site of human angiogenin as revealed by X-ray crystallography. Leonidas DD, Chavali GB, Jardine AM, Li S, Shapiro R, Acharya KR. Protein Sci; 2001 Aug 01; 10(8):1669-76. PubMed ID: 11468363 [Abstract] [Full Text] [Related]